Eczema Society of Canada awards their Seal of Acceptance to DermaSilk® Therapeutic Clothing, marking the first time this seal has been awarded for a clothing product

VICTORIA, BC, April 14 /CNW/ - After careful review of clinical and safety data by their medical panel, The Eczema Society of Canada has accepted DermaSilk® for use by persons with eczema and or sensitive skin conditions. The acceptance is not a direct endorsement, rather, the goal of the Seal of Acceptance program is patient empowerment, education and support.  The Eczema Society's goal is to work toward bettering the health and quality of life for eczema sufferers.

"We are thrilled to see DermaSilk® recognized by an independent scientific review," says Dan Sharp, CEO of Western Allergy Services regarding the Society's Seal of Acceptance. "DermaSilk® offers an innovative approach to the treatment of eczema and we are pleased to see it acknowledged as a viable part of the treatment regime by Canada's skin care experts."

DermaSilk® is a breakthrough in the treatment of eczema and other forms of atopic dermatitis and shows that what you wear can alter the effect of your eczema treatment.

Scientists involved in treating allergic skin conditions such as atopic dermatitis and eczema have turned their attention to the type of clothing worn by patients and have come up with a modernized fabric which has been shown in clinical trials to offer significant advantages over commonly used clothing. This innovative product range is now available in Canada through Western Allergy Services, a Canadian company with over 35 years of expertise in the treatment of allergic disease

DermaSilk® Therapeutic Clothing offers a patented approach to managing skin conditions for all age groups and for any part of the body. Comprised of a range of light-weight therapeutic clothing made of hypoallergenic medical grade 100% silk fibroin, DermaSilk® is also embedded with a special permanent and chemical free antimicrobial protection shield (AEM 5772/5). This antimicrobial fabric is the same one that has been used in operating rooms over the past 30 years.

By combining the properties of knitted pure silk fibroin (softness, high breathing and heat-regulating capacity) and of the antimicrobial shield, DermaSilk® helps to restore the barrier function of the skin, altered by flares, irritations and infections associated with atopic dermatitis. Unlike bioactive fabrics containing silver, the bonded antimicrobial protects against a wide range of microbes without releasing chemicals onto the skin.

DermaSilk® provides the nearest thing to a second skin for the management of allergic skin conditions.

Atopic dermatitis takes a toll on Canadians

It is estimated that 15-20 percent of Canadians1 suffer from eczema and/or atopic dermatitis. Eczema and/or any other form of atopic dermatitis is a multi-faceted condition, varying in duration, extent and severity amongst patients.  Consequently, the delivery of patient care has nearly as many variations as there are eczema patients in Canada. The Eczema Society of Canada recommends the 'Triangle of Control'.  This triad combination involves an emphasis on hydration, medication management, and education. DermaSilk® offers an additional aid in eczema care.

Studies indicate that atopic dermatitis imposes a significant financial burden as well, with total costs estimated at Cdn $1.4 billion annually.  A recent Canadian review2 cited that more than half of patients with atopic dermatitis experience sleep disturbances owing to their condition and 71% have reported concerns about topical corticosteroid use.  The study concluded that the total cost to society is large and that most of the cost is borne by patients and their employers.  A drug free solution such as DermaSilk® is a breakthrough that is long overdue.

The worst and most difficult elements to control are the itching and scratching which leads to weeping and bleeding skin resulting in discomfort, sleepless nights and possible infections. Until now there have been few dressing options that can alleviate this condition.  Cost benefit analysis of DermaSilk® has been shown to greatly reduce the medication costs to patients and the health care system from 75% with mild to moderate sufferers to a whopping 596% for severe patients.  In recognition of this cost savings, health authorities in Europe and the UK now include DermaSilk® in the list of prescribed items covered by National Health Services.

Clinical Trials

In published clinical trials3,4,5, the patented DermaSilk® system has been proven to rapidly and significantly outperform cotton clothing in contributing to the reduction of irritation, itching and scratching associated with compromising skin conditions such atopic dermatitis, while enhancing the activity of conventional medication4.  This ultimately enables patients to increase comfort, heal faster, sleep better and reduce their use of topical antibiotics and steroids.

Dr. Rupert Mason, medical advisor to DermSilk® in the UK, said: "Eczema can be one of the most distressing conditions that children can suffer and it torments them in many ways. The introduction of the DermaSilk® clothing range has many benefits not only for its therapeutic value but also in its design and construction, as the range looks very normal, reducing the self-conscious element children feel in front of their peer group."

DermaSilk® Therapeutic Clothing is available for all age groups and for any part of the body. It is used for eczema and a growing list of other skin disorders, including acne, burn care, diabetic ulcers, lichen sclerosis, thrush, and Epidermolysis bullosa.  The DermaSilk® range includes undershirts, pants, baby suits, gloves, underwear and leggings. DermaSilk® can be ordered directly from Western Allergy Services via their web site, or from select pharmacies and medical professionals.

References: 1. Eczema society of Canada: quoted March 15, 2011. 2. Barbeau M, Lalonde H: Burden of Atopic dermatitis in Canada. International Journal of Dermatology 2006, 45, 31-36. 3.Ricci G, Patrizi A, Bendandi B, Menna G, Varotti, E, Masi M. Clinical effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 2004: 150: 127-31. 4.Senti G, Steinmann LS, Fischer B, Kurmann R, Storni T, Johansen P, Schmid-Grendelmeier P, Wuthrich B, Kundig TM: Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. Dermatology 2006; 213:228-233. 5.Stinco G, Piccirillo F, Valent F: A Randomized Double-Blind Study to Investigate the Clinical Efficacy of Adding a Non-Migrating Antimicrobial to a Special Silk Fabric in the Treatment of Atopic Dermatitis. Dermatology 2008;217:191-195.

/NOTE TO PHOTO EDITORS: The photo accompanying this release is also available at Images are free to accredited members of the media/

SOURCE Western Allergy Services

For further information:

Western Allergy Services
Ms. Genevieve Grant

For more information about the Eczema Society of Canada, contact:
Amanda Cresswell-Melville, Executive Director

Organization Profile

Western Allergy Services

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890